For instance, SCUBE2 is commonly downregulated in non-small-cell lung cancer (NSCLC) [144], glioma tissues [145], colorectal cancer tissues [146], parathyroid adenoma tissues [147], gastric carcinoma tissues [148], and invasive regions of bladder cancer [149]. Here, SCUBE2 is linked to central nervous system cancer.